Oragenics-Intrexon Collaboration Announces Significant Progress Towards Commercial Production of Lead Lantibiotic MU1140

[Business Wire] – Oragenics, Inc. announced today that its Exclusive Channel Collaboration with Intrexon Corporation, a synthetic biology company, has produced an exponential increase in the fermentation titer of the target compound MU1140 and the discov more

View todays social media effects on OGEN

View the latest stocks trending across Twitter. Click to view dashboard

See who Oragenics is hiring next, click here to view